.Basilea Pharmaceutica's job creating new antifungals has actually gotten a substantial improvement ...
.Having presently gathered up the united state legal rights to Capricor Therapies' late-stage Duchen...
.After pushing back the choice date for Applied Therapeutics' metabolic ailment drug govorestat, the...
.Novo Nordisk is continuing its push into hereditary medicines, accepting to pay NanoVation Rehabs a...
.Innovent Biologics has actually helped make the instance that its own gate inhibitor-cytokine fusio...
.A period 3 test of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (...
.5 months after Rakovina Rehabs turned toward expert system, the cancer-focused biotech has actually...
.Ascendis Pharma has actually emerged as a potential hazard to BioMarin's Voxzogo, stating stage 3 d...
.Though Alkeus Pharmaceuticals' oral eye disease possession fell short to substantially minimize geo...
.With a trio of biotechs hitting the Nasdaq on Friday, it was actually very easy to miss out on a sm...
.Invulnerable gate inhibitors are actually the superheroes of cancer cells treatment. Drugs like Bri...
.Accept to today's Chutes & Ladders, our summary of considerable leadership hirings, firings as w...
.Regeneron is back along with long-lasting follow-up for its LAG-3 inhibitor as well as PD-1 inhibit...
.AstraZeneca has actually shared an early consider the performance of its own internal antibody-drug...
.After introducing a phase 3 launch based upon beneficial midstage end results, iTeos and GSK are ac...
.The FDA must be even more open and collective to unleash a surge in approvals of unusual health con...
.It is actually an abnormally active Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bi...
.Atea Pharmaceuticals' antiviral has actually fallen short one more COVID-19 test, but the biotech s...
.Neurocrine Biosciences' mental illness system pivot has neglected. The biotech was actually incapab...
.Sanofi has actually brought in an overdue access to the radioligand celebration, paying for one hun...